New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
04:55 EDTGLYC, GLYC, GLYCGlycoMimetics management to meet with Jefferies
Meetings to be held in the Mid-Atlantic area July 28-29 hosted by Jefferies.
News For GLYC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 19, 2015
09:32 EDTGLYCGlycoMimetics to present preclinical data on GMI-1359 at AACR annual meeting
GlycoMimetics announced that new preclinical research on tumor growth and metastases and the potential value of its newest drug candidate, GMI-1359, will be presented at the American Association for Cancer Research Annual Meeting 2015 in Philadelphia. "Two posters will summarize research data on GMI-1359, a dual acting antagonist of both E-selectin and CXCR4, demonstrating its anti-tumor activity both alone and in combination with chemotherapy in preclinical models of pancreatic and prostate tumor growth. A third poster reports on preclinical studies where GMI-1271, an E-selectin specific antagonist, demonstrates complimentary yet differing roles of E-selectin and CXCR4 in breast cancer metastasis to bone," said the company. “Our initial data supports further evaluation of our E-selectin-CXCR4 antagonist and its potential role in addressing a variety of cancers, including those giving rise to bone metastases,” said John Magnani, Ph.D., GlycoMimetics VP and Chief Scientific Officer. “We... plan to continue our studies of this promising drug and a novel approach to addressing some of the most difficult to treat cancers.”
March 17, 2015
06:11 EDTGLYCGlycoMimetics files $150M mixed securities shelf
Subscribe for More Information
March 16, 2015
16:37 EDTGLYCGlycoMimetics reports Q4 EPS (39c), consensus (22c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use